Healios KK (4593) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Elan Corp.

Fuji Pharma Co., Ltd.

Daito Pharmaceutical Co., Ltd.

Koa Shoji Holdings Co., Ltd.

CellSource Co., Ltd.

Taiko Pharmaceutical Co., Ltd.

Healios KK

Fuso Pharmaceutical Industries Ltd.

Noile-Immune Biotech, Inc.

Seikagaku Corp.

SanBio Co., Ltd.

Why is Healios KK ?

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Operating profit has grown by an annual rate 6.63% of over the last 5 years

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 46.10%, its profits have risen by 20.7%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Healios KK for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Healios KK

46.1%

1.45

92.26%

Japan Nikkei 225

36.73%

1.30

28.24%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

142.58%

EBIT Growth (5y)

6.63%

EBIT to Interest (avg)

-4.46

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.69

Sales to Capital Employed (avg)

0.06

Tax Ratio

5.82%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

22.44

EV to EBIT

-15.49

EV to EBITDA

-17.44

EV to Capital Employed

-30.25

EV to Sales

68.99

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-223.43%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company

ROCE(HY)

Highest at -63.77%

RAW MATERIAL COST(Y)

Fallen by -3.73% (YoY

PRE-TAX PROFIT(Q)

Highest at JPY 2,010 MM

NET PROFIT(Q)

Highest at JPY 1,929 MM

EPS(Q)

Highest at JPY 18.89

-14What is not working for the Company

INTEREST(9M)

At JPY 1,521 MM has Grown at 27.6%

NET SALES(HY)

At JPY 44 MM has Grown at -15.38%

OPERATING CASH FLOW(Y)

Lowest at JPY -3,165 MM

OPERATING PROFIT(Q)

Lowest at JPY -939 MM

Here's what is working for Healios KK

Pre-Tax Profit

At JPY 2,010 MM has Grown at 317.77%

over average net sales of the previous four periods of JPY -923 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit

At JPY 1,929 MM has Grown at 298.35%

over average net sales of the previous four periods of JPY -972.5 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (JPY MM)

Pre-Tax Profit

Highest at JPY 2,010 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

Highest at JPY 1,929 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS

Highest at JPY 18.89

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Raw Material Cost

Fallen by -3.73% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Healios KK

Interest

At JPY 1,521 MM has Grown at 27.6%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Sales

At JPY 44 MM has Grown at -15.38%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (JPY MM)

Operating Cash Flow

Lowest at JPY -3,165 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (JPY MM)

Operating Profit

Lowest at JPY -939 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (JPY MM)